Show notes at pharmacyjoe.com/episode918. In this episode, I’ll discuss the impact of giving a full-dose cephalosporin challenge to patients with a moderate, severe, or unknown beta-lactam allergy.

Show notes at pharmacyjoe.com/episode917. In this episode, I’ll discuss the impact of achieving an aggressive PK/PD target for beta lactams in critically ill patients.

Show notes at pharmacyjoe.com/episode916. In this episode, I’ll discuss the 4 categories of interventions to treat medication overdose and why antidote is not #1.

Show notes at pharmacyjoe.com/episode915. In this episode, I’ll discuss the rare case when a very hypotonic solution may be indicated.

Show notes at pharmacyjoe.com/episode914. In this episode, I’ll discuss oral vs IV phosphate replacement for critically ill patients with mild to moderate hypophosphatemia.

Show notes at pharmacyjoe.com/episode913. In this episode, I’ll discuss the efficacy tradeoff when reducing apixaban dose in patients with end-stage renal disease.

Show notes at pharmacyjoe.com/episode912. In this episode, I’ll discuss whether standard doses of apixaban are as effective as warfarin in severe obesity.

Show notes at pharmacyjoe.com/episode911. In this episode, I’ll discuss the risk of bacteremia in patients with asymptomatic bacteriuria and altered mental status.

Show notes at pharmacyjoe.com/episode911. In this episode, I’ll discuss the risk of bacteremia in patients with asymptomatic bacteriuria and altered mental status.

Show notes at pharmacyjoe.com/episode910. In this episode, I’ll discuss how to judge whether a journal is reputable.

Show notes at pharmacyjoe.com/episode910. In this episode, I’ll discuss how to judge whether a journal is reputable.

Show notes at pharmacyjoe.com/episode909. In this episode, I’ll discuss a novel metric for antibiotic stewardship.

Show notes at pharmacyjoe.com/episode909. In this episode, I’ll discuss a novel metric for antibiotic stewardship.

Show notes at pharmacyjoe.com/episode908. In this episode, I’ll discuss the consolidated CHEST guidelines on antithrombotic therapy for venous thromboembolism disease.

Show notes at pharmacyjoe.com/episode908. In this episode, I’ll discuss the consolidated CHEST guidelines on antithrombotic therapy for venous thromboembolism disease.

Show notes at pharmacyjoe.com/episode907. In this episode, I’ll discuss what predicts critical care pharmacist intervention – patient acuity or medication regimen complexity?

Show notes at pharmacyjoe.com/episode907. In this episode, I’ll discuss what predicts critical care pharmacist intervention – patient acuity or medication regimen complexity?

Show notes at pharmacyjoe.com/episode906. In this episode, I’ll discuss the mortality rate for critically ill patients when ketamine vs etomidate is used as an induction agent for intubation.

Show notes at pharmacyjoe.com/episode906. In this episode, I’ll discuss the mortality rate for critically ill patients when ketamine vs etomidate is used as an induction agent for intubation.

Show notes at pharmacyjoe.com/episode905. In this episode, I’ll discuss which antibiotic should be given first in sepsis – the beta-lactam or the vancomycin?

Show notes at pharmacyjoe.com/episode905. In this episode, I’ll discuss which antibiotic should be given first in sepsis – the beta-lactam or the vancomycin?

Show notes at pharmacyjoe.com/episode904. In this episode, I’ll discuss whether patients taking beta-blockers require increased doses of epinephrine for anaphylaxis.

Show notes at pharmacyjoe.com/episode904. In this episode, I’ll discuss whether patients taking beta-blockers require increased doses of epinephrine for anaphylaxis.

Show notes at pharmacyjoe.com/episode903. In this episode, I’ll discuss the association between number of learners trained per year and rates of burnout among inpatient pharmacists.